Received Mar 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLUR4 | INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) | PROTEIN SCIENCES CORPORATION | UNK | — | OT |
experienced chills immediately after injection for about 20 min; Initial information received on 19-Mar-2025 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional. This case involves an unknown age and unknown gender patient who experienced chills immediately after injection for about 20 min, after receiving Influenza Quadrivalent Recombinant Vaccine [Flublok QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received (1 dosage form, once) dose of suspect Influenza Quadrivalent Recombinant Vaccine, Intravenous infusion (strength: not reported) (lot number, expiry date: not reported) via intramuscular route in unknown administration site for flu (Influenza). On an unknown date the patient developed chills immediately after injection for about 20 min (chills) (unknown latency) following the administration of Influenza Quadrivalent Recombinant Vaccine. No lab data reported. Action taken: not applicable. It was not reported if the patient received corrective treatment for the event. At time of reporting, the outcome was Recovered / Resolved on an unknown date for the event (duration: 20 minutes)